Showing results 1 to 4 of 4
A Combined Chemoimmunotherapy Approach Using a Plasmid-Doxorubicin Complex Bagalkot, Vaishali; Lee, In-Hyun; Yu, Mi Kyung; Lee, Eunhye; Park, Saeho; Lee, Jae-Hyuk; Jon, Sangyong, MOLECULAR PHARMACEUTICS, v.6, no.3, pp.1019 - 1028, 2009-05 |
A duplex oligodeoxynucleotide-dendrimer bioconjugate as a novel delivery vehicle for doxorubicin in in vivo cancer therapy Lee, In-Hyun; Yu, Mi Kyung; Kim, In Hwa; Lee, Jae-Hyuk; Park, Tae Gwan; Jon, Sangyong, JOURNAL OF CONTROLLED RELEASE, v.155, pp.88 - 95, 2011-10 |
Protease-activatable cell-penetrating peptide possessing ROS-triggered phase transition for enhanced cancer therapy Yoo, Jisang; Rejinold, N. Sanoj; Lee, DaeYong; Jon, Sangyong; Kim, Yeu-Chun, JOURNAL OF CONTROLLED RELEASE, v.264, pp.89 - 101, 2017-10 |
Targeted chemoimmunotherapy using drug-loaded aptamer-dendrimer bioconjugates Lee, In-Hyun; An, Sukyung; Yu, Mi Kyung; Kwon, Ho-Keun; Im, Sin-Hyeog; Jon, Sangyong, JOURNAL OF CONTROLLED RELEASE, v.155, no.3, pp.435 - 441, 2011-11 |
Discover